BMS Expands AI Drug Discovery with Schrödinger Platform
Bristol Myers Squibb (BMS) has entered into a strategic agreement with Schrödinger to integrate Bunsen, an AI co-scientist platform, into its ongoing research operations....
UK Launches BARBARA Platform to Speed Up Dementia Drug Tests
A nationwide virtual registration system known as the BARBARA platform has been introduced through a joint effort involving the U.K. government, charities, and the...
Machine Learning Driving Predictive Toxicology in Drug Tests
For decades, the journey of bringing a new medicine from concept to patient has been fraught with challenges, not least among them the intricate...
Novartis to Acquire Myricx Bio to Expand Oncology Pipeline
Novartis has entered into a definitive agreement to purchase the United Kingdom-based biotechnology firm Myricx Bio. This acquisition is valued at a total of...
Generative AI Advancing Drug Research for Novel Therapeutics
The arduous journey of bringing a new drug from concept to patient has historically been fraught with staggering costs, extensive timelines, and a dishearteningly...
AI Drug Target Discovery Unmasks Neurodegenerative Diseases
Neurodegenerative diseases represent one of the most formidable medical and societal challenges of our time. Conditions like Alzheimer's, Parkinson's, Amyotrophic Lateral Sclerosis (ALS), and...
AI Drug Discovery Fast-tracking Search for Cancer Treatment
The relentless pursuit of effective cancer treatments has long been a defining challenge in medical science. For decades, the arduous journey from a promising...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...